U.S. Software Stock News

NasdaqGS:FULT
NasdaqGS:FULTBanks

Fulton Financial HR Shift Puts Focus On Execution And Culture

Fulton Financial (NasdaqGS:FULT) has announced the retirement of Chief Human Resources Officer Bernadette Taylor. Karen Grafje, an internal leader with extensive industry experience, has been promoted to Chief Human Resources Officer. The transition places Grafje in a key role overseeing talent, culture, and workforce initiatives across the company. For investors tracking Fulton Financial at a share price of $20.01, this leadership change follows a mixed stretch of recent stock performance...
NasdaqCM:PRTH
NasdaqCM:PRTHDiversified Financial

Priority Technology Holdings (PRTH) Profit Swing Reinforces Bullish Margin Narratives

Latest FY 2025 earnings snapshot Priority Technology Holdings (PRTH) has wrapped up FY 2025 with fourth quarter revenue of US$247.1 million and EPS of US$0.11, while trailing twelve month EPS sat at US$0.70 on revenue of US$953.0 million. Over recent periods the company has seen revenue move from US$227.1 million in Q4 2024 to US$247.1 million in Q4 2025, with quarterly EPS shifting from a loss of US$0.05 in Q4 2024 to a profit of US$0.11 in Q4 2025 and TTM EPS climbing from a loss of US$0.31...
NYSE:NIO
NYSE:NIOAuto

NIO (NIO) Posts Rare Q4 Profit Challenging Persistent Loss-Making Narrative

NIO (NIO) has closed out FY 2025 with Q4 revenue of C¥34.7b and basic EPS of C¥0.05, alongside trailing twelve month revenue of C¥87.5b and a trailing basic EPS loss of C¥6.85. This puts a spotlight on how quickly the earnings line is moving relative to the top line. The company has seen quarterly revenue move from C¥19.7b and a basic EPS loss of C¥3.45 in Q4 2024 to C¥34.7b and basic EPS of C¥0.05 in Q4 2025. Over the same period, trailing twelve month revenue shifted from C¥65.7b with a...
NYSE:ADCT
NYSE:ADCTBiotechs

ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative

ADC Therapeutics (ADCT) closed out FY 2025 with Q4 revenue of US$23.1 million and a basic EPS loss of US$0.04, alongside net income excluding extra items of a US$6.4 million loss. The company has seen quarterly revenue move from US$16.9 million in Q4 2024 to US$23.1 million in Q4 2025, while basic EPS losses shifted from US$0.29 to US$0.04 over the same period. This sets the stage for investors to focus on how these headline figures translate into the quality and direction of margins. See our...
NYSE:AHR
NYSE:AHRHealth Care REITs

How Investors Are Reacting To American Healthcare REIT (AHR) Equity Raise And Higher 2026 Guidance

In late February 2026, American Healthcare REIT, Inc. completed an at-the-market follow-on equity offering raising about US$769.86 million across multiple common stock tranches and reported fourth-quarter 2025 results showing revenue of US$604.08 million and net income of US$10.78 million. The company also issued 2026 guidance calling for higher net income and same-store net operating income growth, while quarterly real estate impairment charges fell sharply year-on-year to US$11.80 million,...
NYSE:GBCI
NYSE:GBCIBanks

Did Softer Margins And EPS Pressure Just Shift Glacier Bancorp's (GBCI) Investment Narrative?

In recent months, Glacier Bancorp reported softer quarterly results, with net interest income growth trailing the wider banking industry and earnings per share falling even as revenue increased. This divergence between rising revenue and declining per-share earnings has raised questions about the bank’s efficiency, cost structure, and overall profitability quality. With concerns mounting over weaker quarterly performance and profitability trends, we’ll now examine how this development...
NYSE:NPK
NYSE:NPKAerospace & Defense

Does National Presto (NPK) Holding Its Dividend Signal Enduring Defense Strength Or Mask Tariff Strains?

National Presto Industries, Inc. has affirmed an annual cash dividend of US$1.00 per share, with an ex-dividend and record date of March 9, 2026, and payment scheduled for March 20, 2026. The dividend decision comes after the company reported very strong 2025 net sales growth driven by fulfilling a sizable Defense segment backlog, while its Housewares/Small Appliance business contended with tariff-related pressures on demand and costs. Next, we’ll examine how the Defense segment’s...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

Does Veeco (VECO) Becoming InP Laser “Tool of Record” Recast Its AI Datacom Narrative?

In early March 2026, Veeco Instruments Inc. reported that a global leader in optical communications and laser manufacturing placed orders for multiple Lumina Metal Organic Chemical Vapor Deposition systems and Spector Ion Beam Sputtering Optical Coating systems to produce indium phosphide lasers for datacom applications. This order effectively designates Lumina as the customer’s production tool of record for InP epitaxy, underlining Veeco’s role in enabling optical transceivers that connect...
NYSE:RSI
NYSE:RSIHospitality

Has Rush Street Interactive (RSI) Run Too Far After Its 108% One-Year Rally?

If you are wondering whether Rush Street Interactive's share price still makes sense after a strong run, looking closely at what you are paying for today versus the underlying fundamentals is a useful place to start. The stock last closed at US$20.73, with returns of 3.9% over the past 7 days, 17.3% over the past 30 days, 7.4% year to date, 108.1% over the past year and a very large gain over 3 years. Recent coverage around Rush Street Interactive has focused on its position in online gaming...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

SharpLink Gaming (SBET) Q3 Profit Swing Challenges Longstanding Loss‑Focused Narratives

Sharplink (NasdaqCM:SBET) just posted its FY 2025 third quarter numbers with total revenue of about US$10.8 million and basic EPS of US$0.70, a sharp contrast to the trailing twelve month EPS of a US$0.02 loss on revenue of roughly US$13.1 million. Over recent quarters the company has reported revenue of roughly US$0.7 million, then US$0.8 million, and most recently US$10.8 million. Over the same period, quarterly EPS has moved from losses of around US$3.08 per share to US$4.27 per share to a...
NYSE:DAN
NYSE:DANAuto Components

Dana (DAN) Is Down 5.3% After Returning To Profit On Lower 2025 Sales - Has The Bull Case Changed?

Dana Incorporated has released its full-year 2025 results, reporting sales of US$7,500 million, net income of US$85 million, and basic and diluted earnings per share of US$0.64, compared with a loss per share in the prior year. What stands out is that Dana returned to profitability despite lower sales than in 2024, implying meaningful improvements in cost control and overall operational performance. Next, we’ll examine how this return to profitability, despite softer sales, may influence...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Is Globalstar (GSAT) Still Attractive After Apple Partnership And Triple Digit Share Gains?

If you are wondering whether Globalstar's current share price really reflects what the business is worth, you are not alone. The stock is down 8.6% over the last week and 1.7% over the last month, yet it still shows a 160.7% return over 1 year and 234.3% over 3 years, which can change how investors think about both potential growth and risk. That kind of share price history tends to come alongside shifting expectations about Globalstar's satellite services, partnerships or sector outlook, as...
NYSE:LW
NYSE:LWFood

Starboard Pressure On Lamb Weston Cost Cuts And Asset Sales Meets Valuation Gap

Starboard Value LP has publicly urged Lamb Weston Holdings to increase its cost savings program, with a heavier focus on SG&A expenses. The activist investor is also pressing the company to review its international footprint, including the possibility of divesting select APAC assets. This push could influence Lamb Weston Holdings' capital allocation priorities and operating approach in the near term. For investors watching NYSE:LW, this development follows a challenging share price period,...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

How Investors Are Reacting To ICFI’s Soft 2025 Results, Higher 2026 Guidance, And Acquisition Push

In late February 2026, ICF International reported fourth-quarter and full-year 2025 results showing lower revenue and earnings year-on-year, reaffirmed its quarterly US$0.14 dividend, outlined 2026 guidance, detailed recent share repurchases, and indicated it is actively seeking acquisitions while reducing debt. An interesting angle for investors is that, despite softer 2025 performance, management is simultaneously guiding to higher 2026 earnings, continuing dividends and buybacks, and...
NYSE:PEG
NYSE:PEGIntegrated Utilities

How Investors May Respond To Public Service Enterprise Group (PEG) Earnings Beat, Dividend Hike, and Upgrade

In late February 2026, Public Service Enterprise Group reported higher fourth-quarter and full-year 2025 results, with sales rising to US$2,915 million and US$12.17 billion and diluted EPS from continuing operations increasing to US$0.63 and US$4.22, respectively, compared with the prior year. Alongside these results, the board approved a quarterly dividend increase to US$0.67 per share and analysts at Evercore ISI upgraded the stock to “Outperform,” highlighting the company’s regulated...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Assessing Coca-Cola Consolidated (COKE) Valuation After Independence Deal And Strong Fundamental Performance

Coca-Cola Consolidated (COKE) has drawn fresh attention after fully buying out Coca-Cola's equity interest for US$2.4b last November. This move leaves the bottler operating as an independent company. See our latest analysis for Coca-Cola Consolidated. The independence deal is landing against a strong run in Coca-Cola Consolidated's shares, with the stock at US$206.91 and a 30-day share price return of 31.17% alongside a 1-year total shareholder return of 69.85%. This suggests momentum has...
NYSE:TFIN
NYSE:TFINBanks

A Look At Triumph Financial (TFIN) Valuation As Recent Momentum Cools And Mixed Signals Emerge

Triumph Financial (TFIN) has been drawing investor attention after recent share price moves, with the stock closing at US$58.38 and posting mixed returns over the past month and past 3 months. See our latest analysis for Triumph Financial. The recent 14.6% 30 day share price decline, alongside a year to date share price return decline of 7.9% and a 2.2% 1 year total shareholder return decline, suggests momentum has cooled after earlier gains and hints that investors are reassessing Triumph...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Is Vericel (VCEL) Pricing Justified After A 30% One-Year Share Price Decline

If you are trying to work out whether Vericel is attractively priced today, it helps to step back and look at both its recent share performance and what the numbers say about value. Vericel shares last closed at US$34.12, with returns of 3.5% decline over 7 days, 5.7% decline over 30 days, a 4.2% decline year to date and a 30.2% decline over the last year, while the 3 year return is 15.3% and the 5 year return is 28% decline. Recent price moves sit against a backdrop of ongoing interest in...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales

In recent weeks, Krystal Biotech reported financial results for the fourth quarter of 2025 that exceeded analyst expectations for both earnings and revenue, while President and CEO Krishnan Krish S executed US$6.58 million of pre-planned stock sales under a Rule 10b5-1 trading plan. This combination of financial outperformance and insider selling offers fresh insight into how management is monetizing equity while the core business appears to be executing ahead of external forecasts. Next,...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?

Immunocore Holdings plc recently reported fourth-quarter 2025 revenue of US$104.48 million and a quarterly net loss of US$30.06 million, alongside full-year 2025 revenue of US$400.02 million and a full-year net loss of US$35.51 million. The company paired this earnings update with a packed schedule of March 2026 healthcare conference appearances in Boston and Miami, signaling active engagement with investors and the broader biotech community. We’ll now examine how the full-year revenue...
NYSE:RBC
NYSE:RBCMachinery

Did Aerospace Backlog Growth And Capacity Expansion Just Shift RBC Bearings' (RBC) Investment Narrative?

RBC Bearings Incorporated recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando and released a mixed quarter, with year-on-year revenue growth supported by its Aerospace & Defense operations and steady Industrial performance. Management highlighted a growing aerospace and defense backlog, a focus on profitable growth, and expanding production capacity, underlining efforts to strengthen long-term cash generation and contract visibility. Next, we’ll...
NYSE:PINE
NYSE:PINEREITs

Should Alpine’s New High‑Coupon Mortgage Loan Strategy Shape How Investors View PINE’s Risk Profile?

Alpine Income Property Trust, Inc. recently originated a US$32.0 million first mortgage loan, funding US$8.6 million at close, to back the development of an 11‑acre, 101,000‑square‑foot retail center with investment grade tenants and three outparcels in the Covington Town Center master plan near Atlanta. The high‑coupon, 24‑month loan tied to a Target‑anchored project adjacent to an existing Publix highlights Alpine’s growing use of higher‑yield structured financing alongside its net lease...
NasdaqCM:RLMD
NasdaqCM:RLMDPharmaceuticals

A Look At Relmada Therapeutics (RLMD) Valuation After NDV‑01 Phase 2 Bladder Cancer Data

Phase 2 NDV-01 data and what it could mean for Relmada Therapeutics (RLMD) Relmada Therapeutics (RLMD) has drawn fresh attention after reporting 12 month interim Phase 2 data for NDV-01 in high risk non muscle invasive bladder cancer, showing strong complete response rates and a favorable safety profile. See our latest analysis for Relmada Therapeutics. The NDV-01 update and recent Leerink healthcare conference appearance came alongside a sharp shift in sentiment, with Relmada Therapeutics’ 1...
NYSE:EPR
NYSE:EPRSpecialized REITs

Will EPR’s Largest Regional Parks Deal Since 2017 Redefine Its Experiential Focused Strategy (EPR)?

EPR Properties recently entered into definitive agreements to acquire seven regional parks from Six Flags Entertainment for a gross transactional value of US$342 million, materially expanding its attractions portfolio across over 1,600 acres and 418 attractions in the U.S. and Canada. This is the company’s largest acquisition since 2017 and further tilts its portfolio toward experiential real estate, with long-term master leases to specialized park operators. Next, we’ll examine how this...